IntroductionAge is a major thrombo-embolic risk factor in atrial fibrillation (AF), but also a risk factor for bleeding under oral anticoagulation therapy (OAC). However, it appears that older patients are inadequately treated with OAC.The objective of our study was to evaluate the use of OAC in elderly patients hospitalised in a cardiology department according to current guidelines.MethodOver a 4-month period, 142 patients over 75 years old with history of AF were included. Clinical and biological data were recorded, and risk scores for bleeding (HASBLED) and thrombo-embolic events (CHADS2 and CHA2DS2VASc) were independently assessed after discharge. The differences between bleeding and thrombo-embolic risk were calculated for each patient...
Background: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact o...
Our objectives were to (1) describe the evolution of the underuse of anticoagulants in older people ...
BACKGROUND: Oral anticoagulants (OAC) are underutilized in older patients with atrial fibrillation, ...
IntroductionAge is a major thrombo-embolic risk factor in atrial fibrillation (AF), but also a risk ...
IntroductionCharacteristics of patients with atrial fibrillation (AF) are well known, however the pa...
Atrial fibrillation (AF) is independently associated with a higher risk of morbidity and mortality, ...
Oral anticoagulant therapy (OAT) with direct oral anticoagulant (DOACs) is the established treatment...
IntroductionDirect oral anticoagulants (DOACs) are underused in the elderly, regardless the evidence...
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation (A...
Introduction and ObjectivesAtrial fibrillation (AF) is associated with a five times higher risk of s...
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias. Its incidence and prevalence...
Background and Objective: Atrial fibrillation (AF), the most common cardiac arrhythmia, typically in...
Background and Objective: Atrial fibrillation (AF), the most common cardiac arrhythmia, typically in...
Non-valvular atrial fibrillation (NVAF) is the most common arrhythmia in older patients. Although di...
Background: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact o...
Background: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact o...
Our objectives were to (1) describe the evolution of the underuse of anticoagulants in older people ...
BACKGROUND: Oral anticoagulants (OAC) are underutilized in older patients with atrial fibrillation, ...
IntroductionAge is a major thrombo-embolic risk factor in atrial fibrillation (AF), but also a risk ...
IntroductionCharacteristics of patients with atrial fibrillation (AF) are well known, however the pa...
Atrial fibrillation (AF) is independently associated with a higher risk of morbidity and mortality, ...
Oral anticoagulant therapy (OAT) with direct oral anticoagulant (DOACs) is the established treatment...
IntroductionDirect oral anticoagulants (DOACs) are underused in the elderly, regardless the evidence...
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation (A...
Introduction and ObjectivesAtrial fibrillation (AF) is associated with a five times higher risk of s...
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias. Its incidence and prevalence...
Background and Objective: Atrial fibrillation (AF), the most common cardiac arrhythmia, typically in...
Background and Objective: Atrial fibrillation (AF), the most common cardiac arrhythmia, typically in...
Non-valvular atrial fibrillation (NVAF) is the most common arrhythmia in older patients. Although di...
Background: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact o...
Background: Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact o...
Our objectives were to (1) describe the evolution of the underuse of anticoagulants in older people ...
BACKGROUND: Oral anticoagulants (OAC) are underutilized in older patients with atrial fibrillation, ...